- Home
- WOW vs ATYR Comparison
WOW vs ATYR Comparison
Compare WOW & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOW
- ATYR
- Stock Information
- Founded
- WOW 2001
- ATYR 2005
- Country
- WOW United States
- ATYR United States
- Employees
- WOW N/A
- ATYR N/A
- Industry
- WOW Cable & Other Pay Television Services
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WOW Telecommunications
- ATYR Health Care
- Exchange
- WOW Nasdaq
- ATYR Nasdaq
- Market Cap
- WOW 375.2M
- ATYR 306.2M
- IPO Year
- WOW 2017
- ATYR 2015
- Fundamental
- Price
- WOW $4.07
- ATYR $5.22
- Analyst Decision
- WOW Buy
- ATYR Strong Buy
- Analyst Count
- WOW 2
- ATYR 6
- Target Price
- WOW $6.50
- ATYR $20.20
- AVG Volume (30 Days)
- WOW 296.1K
- ATYR 2.5M
- Earning Date
- WOW 08-07-2025
- ATYR 08-12-2025
- Dividend Yield
- WOW N/A
- ATYR N/A
- EPS Growth
- WOW N/A
- ATYR N/A
- EPS
- WOW N/A
- ATYR N/A
- Revenue
- WOW $619,400,000.00
- ATYR N/A
- Revenue This Year
- WOW N/A
- ATYR $960.85
- Revenue Next Year
- WOW N/A
- ATYR $1,283.47
- P/E Ratio
- WOW N/A
- ATYR N/A
- Revenue Growth
- WOW N/A
- ATYR N/A
- 52 Week Low
- WOW $3.87
- ATYR $1.42
- 52 Week High
- WOW $5.80
- ATYR $5.98
- Technical
- Relative Strength Index (RSI)
- WOW 44.52
- ATYR 62.87
- Support Level
- WOW $3.87
- ATYR $5.02
- Resistance Level
- WOW $4.11
- ATYR $5.98
- Average True Range (ATR)
- WOW 0.13
- ATYR 0.45
- MACD
- WOW -0.01
- ATYR -0.04
- Stochastic Oscillator
- WOW 50.00
- ATYR 52.94
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.